Navigation Links
Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2009
Date:8/13/2009

617-801-6888 (international callers), using passcode 53658791.

About Insmed

Insmed Inc. is a biopharmaceutical company with unique protein development experience and a proprietary protein platform aimed at niche markets with unmet medical needs. For more information, please visit http://www.insmed.com.

Forward-Looking Statements

This release contains forward-looking statements which are made pursuant to provisions of Section 21E of the Securities Exchange Act of 1934. Investors are cautioned that such statements in this release, including statements relating to business strategies, plans and objectives of management and our strategic review process, constitute forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the forward-looking statements. The risks and uncertainties include, without limitation, we may be unsuccessful in identifying or reaching agreement with acquisition or merger candidates, our expenses may be higher than anticipated and other risks and challenges detailed in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2008. Readers are cautioned not to place undue reliance on any forward-looking statements which speak only as of the date of this release. We undertake no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances that occur after the date of this release or to reflect the occurrence of unanticipated events.

                      INSMED INCORPORATED
                   Consolidated Balance Sheets
        (in thousands, except share and per share data)

             
'/>"/>
SOURCE Insmed Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Insmed Provides Update on Supply of IPLEX(TM)
2. Insmed Completes Sale of Follow-On Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million
3. Insmed Announces FDA Issues Statement Regarding Position on Allowing Patients With ALS Access to IPLEX(TM) Under an IND
4. Insmed and Premacure Announce European Orphan Designation for IPLEX(TM) in Retinopathy of Prematurity in Infants
5. Insmed Gains Royalty-Free Worldwide Rights for IPLEX(TM) in Connection with Potential Expanded Access ALS Programs
6. Insmed to Present at Upcoming Healthcare Conferences
7. Insmed to Present at the IBC 5th Annual Global Follow-On Biologics Conference
8. Westaim announces 2009 second quarter results
9. eDiets.com(R) Announces Q2 2009 Results
10. Nutrition 21 Announces Preliminary Fourth Quarter Financial Update Also Announces Negotiations on Notes due August 25, 2009
11. Procter & Gamble Announces Appointment of Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... Bedros Keuilian is not only the founder ... camps, he’s also considered the leading expert on marketing ... business summits, a line of high-demand fitness marketing systems ... Spike TV reality show to his name. , With ... for personal trainers and fitness business owners to focus ...
(Date:10/1/2014)... WASHINGTON, D.C. and ATLANTA (PRWEB) October 01, ... and information security executive networking and relationship-marketing ... the 2014 Information Security Executive® and Project ... Executives include top-ranking decision makers representing organizations ... and academics. Projects include large-scale technology endeavors ...
(Date:10/1/2014)... Beverly Hills licensed Clinical Psychologist and ... 20 years of private practice in her Beverly Hills ... achieve greater joy and fulfillment in their relationships. Dr. ... and suggestions for anyone who suspects they are in ... it or not, it’s not always easy to know ...
(Date:10/1/2014)... NoteSwift Inc., announced today their new NoteSwift™ ... 13.0. NoteSwift is the bridge between the EHR and ... document clinical information at the point of care. NoteSwift ... note by more than half – and virtually eliminates ... providers state impedes EHR use according to the June ...
(Date:10/1/2014)... Today in Bahir Dar, Ethiopia, at the occasion ... has gathered some 150 African and international leishmaniasis ... treatment safety and efficacy monitoring plan, carried ... Kenya, Sudan, Uganda, and Ethiopia, were presented to ... access to treatment of kala-azar with the combination ...
Breaking Medicine News(10 mins):Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 3Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 2Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 3Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 4Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 5Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 6Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 7Health News:Prominent Beverly Hills Psychologist Dr. Kathleen Mojas Celebrating 20 Years in Private Practice Identifies Common Warning Signs That You May Be In a Toxic Relationship. 2Health News:Prominent Beverly Hills Psychologist Dr. Kathleen Mojas Celebrating 20 Years in Private Practice Identifies Common Warning Signs That You May Be In a Toxic Relationship. 3Health News:NoteSwift Joins Allscripts Developer Program 2Health News:NoteSwift Joins Allscripts Developer Program 3Health News:Results of large-scale roll out of combination treatment for kala-azar in Eastern Africa 2
... memory, language, and other cognitive skills after bypass surgery. ... or the pump used to replace heart function during ... The findings may lead to better approaches to prevent ... receive. , The study, published in the May Annals ...
... Murad, Inc. announced today,the appointment of Fernando ... Business for Latin America. In this position, Braga ... presence in key,areas, identify prospective partners and create ... http://www.newscom.com/cgi-bin/prnh/20080519/LAM066 ), "Fernando joins the Murad ...
... Diego, California, May 19, 2008 NPS Pharmaceuticals, Inc. ... data at the annual Digestive Disease Week (DDW) Congress ... reduce dependence upon parenteral nutrition (PN) in patients with ... , The Phase 3 study evaluated two ...
... ARLINGTON HEIGHTS, Ill., May 19 Plastic,surgeons performed ... ranging from repairing dog bite wounds and birth ... (Photo: http://www.newscom.com/cgi-bin/prnh/20080519/DC22812 ), Who ... has reconstructive,surgery changed their lives?, On average, ...
... The Epilepsy,Foundation today released important information about epilepsy and ... recent news about,Senator Edward Kennedy (D-Mass)., Senator Kennedy, ... S.,Senate, reportedly experienced a seizure on Saturday. A seizure ... One in ten Americans,will have a single seizure at ...
... smoke, chemicals boosts odds, but routine screening could ... may be at increased risk for bladder cancer and ... of California, San Francisco, researchers. , The team tested ... age was 45, and found that 93 tested ...
Cached Medicine News:Health News:Bypass not to blame for heart patients' mental decline 2Health News:Murad, Inc., Appoints Fernando Braga, Jr. as Director of International Business for Latin America 2Health News:Phase 3 GATTEX results presented at DDW highlight potential new treatment in short bowel syndrome 2Health News:Phase 3 GATTEX results presented at DDW highlight potential new treatment in short bowel syndrome 3Health News:Phase 3 GATTEX results presented at DDW highlight potential new treatment in short bowel syndrome 4Health News:Each Day, Plastic Surgeons Are Reconstructing Lives: Restoring Function, Improving Appearances, and Elevating Self-Esteem 2Health News:The Epilepsy Foundation Sheds Light on Seizures 2Health News:Firefighters May Face Higher Risk of Bladder Cancer 2
(Date:10/1/2014)... SAN MARCOS, Texas , Oct. 1, 2014 ... that it is scaling volume production of photoactive ... solar power technologies . While offering numerous advantages ... difficulty of producing large quantities of quantum dots ... has until now kept them from commercial utilization ...
(Date:10/1/2014)... 1, 2014 Ardelyx, Inc. (NASDAQ: ... company focused on cardio-renal, gastrointestinal and metabolic ... 371 patient Phase 2b clinical trial evaluating ... syndrome (IBS-C).  Results from this study demonstrated ... IBS-C symptoms for tenapanor-treated patients compared to ...
(Date:10/1/2014)... , Switzerland , October 1, ... leader in Clinical Genomics and Next Generation Sequencing (NGS) ... allowing clinicians to run full cystic fibrosis analysis in ... the identification and characterisation of all types of variants ... performance. Until now, it has not been ...
Breaking Medicine Technology:Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 2Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 3Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 2Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 3Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 4Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 5Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 6Sophia Genetics Launches Full CFTR Analysis in Single Clinical Grade NGS Experiment 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: